- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2015
- Public Summary Document (PSD) July 2015 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2015 PBAC Meeting - Word
Ponatinib – July 2015
Ponatinib; 15 mg tablet, 60; 45 mg tablet, 30; Iclusig®
Last updated
1 November 2015